S. Hussain, T. Shalem, D. Leung, P. Raj, David M. Troendle, A. Shannon, S. Acra, Annette Vannilam, H. Shirin, E. Broide
{"title":"Safety and efficacy of the point-of-care BreathID®Hp and BreathID®Hp Lab System 13C-Urea breath test for the detection of H. pylori in children","authors":"S. Hussain, T. Shalem, D. Leung, P. Raj, David M. Troendle, A. Shannon, S. Acra, Annette Vannilam, H. Shirin, E. Broide","doi":"10.15761/pd.1000188","DOIUrl":null,"url":null,"abstract":"Despite the fact that urea breath test (UBT) for the diagnosis of Helicobacter pylori (H. pylori) has high sensitivity and specificity, the accuracy of UBT in pediatrics is less than that of adults. The aim of the current study was to prospectively determine the safety and the diagnostic accuracy of the 13C-UBT for the detection of H. pylori using the point-of-care continuous BreathID®Hp and the breath sampling bag test, BreathID®Hp Lab System, in a pediatric population. Fifty-three children performed the 13C-UBT via both the BreathID®Hp and the BreathID® Hp Lab System and were asked to provide a stool sample for conventional H. pylori antigen testing. BreathID®Hp sensitivity was 93.3% [95% CI (68.05%; 99.83%)] and specificity was 100% [95% CI (86.77%; 100.00%)] compared to stool antigen. The overall agreement in detection of H. pylori using the BreathID®Hp breath test versus the stool antigen test was 97.56% [95% CI (87.14%; 99.94%)]. BreathID®Hp Lab System sensitivity was 93.3% [95% CI (68.05%; 99.83%)] and specificity was 100% [95% CI (87.23%; 100.00%)] compared to stool antigen. The overall agreement in detection of H. pylori using the BreathID®Hp Lab System breath test versus the stool antigen test was 97.62% [95% CI (87.43%; 99.94%)]. One minor possibly related adverse event was recorded. Conclusions: Both the BreathID®Hp and the BreathID®Hp Lab System breath sample collection devices were safe and accurate in diagnosis of H. pylori infection in children. *Correspondence to: Sunny Z Hussain, Willis-Knighton Pediatric GI Specialist/ Willis-Knighton Health System, Shreveport, LA, USA, Tel: 318-212-5858; Fax 318212-5877; E-mail: Shussain@wkhs.com Tzippora Shalem, The Kamila Gonczarowski Institute of Gastroenterology, Shamir (Assaf Harofeh) Medical Center and the Sackler School of Medicine, Tel Aviv University, Israel, E-mail: tzippi.shalem@gmail.com","PeriodicalId":91786,"journal":{"name":"Pediatric dimensions","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric dimensions","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15761/pd.1000188","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Despite the fact that urea breath test (UBT) for the diagnosis of Helicobacter pylori (H. pylori) has high sensitivity and specificity, the accuracy of UBT in pediatrics is less than that of adults. The aim of the current study was to prospectively determine the safety and the diagnostic accuracy of the 13C-UBT for the detection of H. pylori using the point-of-care continuous BreathID®Hp and the breath sampling bag test, BreathID®Hp Lab System, in a pediatric population. Fifty-three children performed the 13C-UBT via both the BreathID®Hp and the BreathID® Hp Lab System and were asked to provide a stool sample for conventional H. pylori antigen testing. BreathID®Hp sensitivity was 93.3% [95% CI (68.05%; 99.83%)] and specificity was 100% [95% CI (86.77%; 100.00%)] compared to stool antigen. The overall agreement in detection of H. pylori using the BreathID®Hp breath test versus the stool antigen test was 97.56% [95% CI (87.14%; 99.94%)]. BreathID®Hp Lab System sensitivity was 93.3% [95% CI (68.05%; 99.83%)] and specificity was 100% [95% CI (87.23%; 100.00%)] compared to stool antigen. The overall agreement in detection of H. pylori using the BreathID®Hp Lab System breath test versus the stool antigen test was 97.62% [95% CI (87.43%; 99.94%)]. One minor possibly related adverse event was recorded. Conclusions: Both the BreathID®Hp and the BreathID®Hp Lab System breath sample collection devices were safe and accurate in diagnosis of H. pylori infection in children. *Correspondence to: Sunny Z Hussain, Willis-Knighton Pediatric GI Specialist/ Willis-Knighton Health System, Shreveport, LA, USA, Tel: 318-212-5858; Fax 318212-5877; E-mail: Shussain@wkhs.com Tzippora Shalem, The Kamila Gonczarowski Institute of Gastroenterology, Shamir (Assaf Harofeh) Medical Center and the Sackler School of Medicine, Tel Aviv University, Israel, E-mail: tzippi.shalem@gmail.com
尽管尿素呼气试验(UBT)诊断幽门螺杆菌(h.p ylori)具有较高的敏感性和特异性,但UBT在儿科的准确性低于成人。本研究的目的是前瞻性地确定13C-UBT在儿科人群中使用即时连续BreathID®Hp和呼吸采样袋测试(BreathID®Hp实验室系统)检测幽门螺杆菌的安全性和诊断准确性。53名儿童通过BreathID®Hp和BreathID®Hp实验室系统进行13C-UBT,并要求提供粪便样本进行常规幽门螺杆菌抗原检测。BreathID®Hp敏感性为93.3% [95% CI (68.05%;99.83%),特异性为100% [95% CI (86.77%;100.00%)]与粪便抗原相比。使用BreathID®Hp呼气试验与粪便抗原试验检测幽门螺杆菌的总体一致性为97.56% [95% CI (87.14%;99.94%)]。BreathID®Hp Lab System灵敏度为93.3% [95% CI (68.05%;99.83%),特异性为100% [95% CI (87.23%;100.00%)]与粪便抗原相比。使用BreathID®Hp Lab System呼气试验与粪便抗原试验检测幽门螺杆菌的总体一致性为97.62% [95% CI (87.43%;99.94%)]。记录了一个可能相关的轻微不良事件。结论:BreathID®Hp和BreathID®Hp Lab System呼吸样本采集装置诊断儿童幽门螺杆菌感染安全、准确。*通信:Sunny Z Hussain,威利斯-奈特顿儿科GI专家/威利斯-奈特顿卫生系统,什里夫波特,洛杉矶,美国,电话:318-212-5858;传真318212 - 5877;Tzippora Shalem,以色列特拉维夫大学Shamir (Assaf Harofeh)医学中心和Sackler医学院的Kamila Gonczarowski胃肠病学研究所,E-mail: tzippi.shalem@gmail.com